Candel Therapeutics, Inc. — SCHEDULE 13G/A Filings
4 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Candel Therapeutics, Inc. (CADL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Candel Therapeutics, Inc. has filed 4 SCHEDULE 13G/A documents with the SEC since 2021. To view all SEC filings by Candel Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001104659-25-049512 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-004195 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000036 | Feb 7, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000411 | Feb 7, 2025 | — |